Hostname: page-component-7479d7b7d-767nl Total loading time: 0 Render date: 2024-07-13T23:40:39.375Z Has data issue: false hasContentIssue false

Treatment of extrapyramidal side-effects

Published online by Cambridge University Press:  02 January 2018

Lenard A. Adler
Affiliation:
Psychiatry Service, New York VAMC, 408 First Avenue at East 24th Street, New York 10010, USA
Erica Duncan
Affiliation:
Psychiatry Service, New York VAMC, 408 First Avenue at East 24th Street, New York 10010, USA
Stewart Reiter
Affiliation:
Psychiatry Service, New York VAMC, 408 First Avenue at East 24th Street, New York 10010, USA
John Rotrosen
Affiliation:
Psychiatry Service, New York VAMC, 408 First Avenue at East 24th Street, New York 10010, USA
Burt Angrist
Affiliation:
Psychiatry Service, New York VAMC, 408 First Avenue at East 24th Street, New York 10010, USA
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1989 

References

Adler, L., Duncan, E., Reiter, S. et al (1988) Effects of calcium channel antagonists on tardive dyskinesia and psychosis. Psychopharmacology Bulletin, 24, 421426.Google ScholarPubMed
Reiter, S., Adler, L. & Angrist, B. et al (1989) Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients. Journal of Clinical Psychiatry, 50, 2627.Google ScholarPubMed
Simpson, G. M. & Angus, J. W. S. (1970) A rating scale for extrapyramidal side-effects. Acta Psychiatrica Scandinavica, Suppl. 212, 1119.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.